Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease
Committee on Qualifications of Biomarkers and Surrogate Endpoints in Chronic Disease,Institute of Medicine
Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease
Committee on Qualifications of Biomarkers and Surrogate Endpoints in Chronic Disease,Institute of Medicine
Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process. –Publisher’s description.
This item is not currently in-stock. It can be ordered online and is expected to ship in approx 4 weeks
Our stock data is updated periodically, and availability may change throughout the day for in-demand items. Please call the relevant shop for the most current stock information. Prices are subject to change without notice.
Sign in or become a Readings Member to add this title to a wishlist.